Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Annamycin in Soft-Tissue Sarcoma with Pulmonary Metastases
NCT04887298Phase 2Completed
- Sponsor
- Moleculin Biotech, Inc.
- Start
- Jun 2021
- Primary completion
- Sep 2022
- Modality
- DNA Intercalators/Alkylators, Targeted Liposomes, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of annamycin in soft tissue sarcoma (STS), sponsored by Moleculin Biotech, Inc.. Started Jun 2021; status: completed.
02
Drugs
annamycin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT04887298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04887298.